• Profile
Close

MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis

New England Journal of Medicine Mar 09, 2020

Ahdoot M, Wilbur AR, Reese SE, et al. - This study sought to present MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. Researchers included a sum of 2,103 men who underwent both biopsy methods. Men with MRI-visible prostate lesions experienced both MRI-targeted and systematic biopsy. The primary endpoint included cancer detection according to grade group (i.e., clustering of Gleason grades). The detection of cancers of grade group 2 or higher and grade group 3 or higher, cancer detection stratified by previous biopsy status, and grade reclassification between biopsy and radical prostatectomy were considered the secondary endpoints. A combined biopsy led to more detection of all prostate cancers among individuals with MRI-visible lesions. Nevertheless, MRI-targeted biopsy alone underestimated the histologic grade of some tumors. The results of this study indicated that, after radical prostatectomy, upgrades to grade group 3 or higher on histopathological analysis were considerably lower after the combined biopsy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay